Using the industry peer median EV/Revenue multiple (trailing + forward), ENvue Medical, Inc. (FEED) has a fair value of $301.12 based on 10 comparable companies in the Medical - Specialties industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing EV/Revenue | Forward EV/Revenue | |
|---|---|---|---|
| ENvue Medical, Inc.FEED | 0 | -0.2x | -2.6x |
| Eli Lilly and Company | 893,194 | 14.2x | 11.1x |
| Johnson & Johnson | 532,766 | 6.0x | 5.6x |
| AbbVie Inc. | 358,669 | 6.9x | 6.3x |
| UnitedHealth Group Incorporated | 335,604 | 0.9x | 0.9x |
| AstraZeneca PLC | 281,935 | 5.2x | 4.8x |
| Novartis AG | 278,639 | 5.6x | 5.3x |
| Merck & Co., Inc. | 275,089 | 4.8x | 4.7x |
| Novo Nordisk A/S | 204,725 | 5.1x | 5.3x |
| Amgen Inc. | 177,882 | 6.1x | 5.9x |
| Thermo Fisher Scientific Inc. | 176,319 | 4.7x | 4.4x |
| Industry Median | 5.4x | 5.3x | |
| (*) Revenue | 3 | 0 | |
| = Enterprise Value | 14 | 1 | |
| (-) Net Debt | -1 | -1 | |
| Equity Value | 14 | 2 | |
| (/) Outstanding shares | 0 | 0 | |
| Fair Price | $534 | $69 | |
Disclaimer: Sweet Value Lab provides estimated intrinsic values for informational purposes only. This is not financial advice. All models rely on assumptions that may not reflect future performance. Always do your own research before making investment decisions.